Deutsch English Français

Contact

EP1003856

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1003856

EP1003856 - APAF-1, THE CED-4 HUMAN HOMOLOG, AN ACTIVATOR OF CASPASE-3 [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 04.06.2004 Database last updated on 24.08.2024
Most recent event Tooltip	04.06.2004	Application deemed to be withdrawn	published on 21.07.2004 [2004/30]
Applicant(s)	For all designated states BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 5323 Harry Hines Boulevard Dallas Texas 75235-9094 / US
	[N/P]
Former [2000/22]	For all designated states Board of Regents, The University of Texas System 5323 Harry Hines Boulevard Dallas, Texas 75235-9094 / US
Inventor(s)	01 / ZOU, Hua 2506A Rampast Dallas, TX 75235 / US
	02 / HENZEL, William, J. 3724 Southwood Avenue San Mateo, CA 94403 / US
	03 / WANG, Xiaodong 4063 Stone Hollow Way Dallas, TX 75287 / US
	[2000/22]
Representative(s)	Goldin, Douglas Michael, et al J.A. KEMP & CO. 14 South Square Gray's Inn London WC1R 5JJ / GB
	[N/P]
Former [2000/22]	Goldin, Douglas Michael, et al J.A. KEMP & CO. 14 South Square Gray's Inn London WC1R 5LX / GB
Application number, filing date	98926395.9	05.06.1998
	[2000/22]
	WO1998US11773
Priority number, date	US19970048807P	05.06.1997 Original published format: US 48807 P
	US19970055258P	07.08.1997 Original published format: US 55258 P
	[2000/22]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9855615
	Date:	10.12.1998
	Language:	EN
	[1998/49]
	Type:	A1 Application with search report
	No.:	EP1003856
	Date:	31.05.2000
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 10.12.1998 takes the place of the publication of the European patent application.
	[2000/22]
Search report(s)	International search report - published on:	EP	10.12.1998
Classification	IPC:	C12N15/12, C12N15/62, C07K14/47, C07K16/18, C07K19/00, C12N5/10, A61K38/17, G01N33/68, A01K67/027	[2000/22]
	CPC:	C07K14/4747 (EP,US); A61P25/00 (EP); A61P35/00 (EP); A61P37/00 (EP); A61P43/00 (EP); A01K2217/075 (EP,US); (+) A61K38/00 (EP,US); C07K2319/00 (EP,US) (-)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2000/22]
Title	German:	APAF-1, MENSCHLUCHES CED-4 HOMOLOG, EIN AKTIVATOR VON CASPASE-3	[2000/22]
	English:	APAF-1, THE CED-4 HUMAN HOMOLOG, AN ACTIVATOR OF CASPASE-3	[2000/22]
	French:	APAF-1, HOMOLOGUE HUMAIN DE CED-4, ACTIVATEUR DE CASPASE-3	[2000/22]
Entry into regional phase	27.12.1999	National basic fee paid
	27.12.1999	Designation fee(s) paid
	27.12.1999	Examination fee paid
Examination procedure	04.01.1999	Request for preliminary examination filed International Preliminary Examining Authority: EP
	27.12.1999	Examination requested [2000/22]
	17.11.2003	Despatch of a communication from the examining division (Time limit: M04)
	01.01.2004	Application deemed to be withdrawn, date of legal effect [2004/30]
	11.02.2004	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2004/30]
Fees paid	Renewal fee
	13.06.2000	Renewal fee patent year 03
	13.06.2001	Renewal fee patent year 04
	12.06.2002	Renewal fee patent year 05
	Penalty fee
	Additional fee for renewal fee
	30.06.2003	06 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[Y]WO9325685 (MASSACHUSETTS INST TECHNOLOGY [US]) [Y] 1-27 * figures 1,3,4; example 1; claims 17-74 *;
		[A]WO9320237 (CAMBRIDGE NEUROSCIENCE INC [US]) [A] 1-4,12-19 * abstract *;
		[X] - EMEST7 database Accession number N92067 Hillier L. et al. 18-APR-1996 (Rel. 47, Created), XP002078071 [X] 15 * the whole document *
		[Y] - SPECTOR MS ET AL, "Interaction between the C. elegans cell-death regulators CED-9 and CED-4.", NATURE, FEB 13 1997, 385 (6617) P653-6, ENGLAND, XP002077927 [Y] 1-27 * abstract * * page 655, column R, paragraph 2 *
		[A] - CHINNAIYAN AM ET AL, "Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death [see comments]", SCIENCE, FEB 21 1997, 275 (5303) P1122-6, UNITED STATES, XP002077928 [A] 1-4,12-19,26,27 * abstract * * page 1124, column L, paragraph 2 - page 1126, column L, paragraph 1 *
		[A] - BAUER, MANUEL K. A. ET AL, "The Caenorhabditis elegans death protein Ced-4 contains a motif with similarity to the mammalian death effector domain", FEBS LETT. (1997), 402(2,3), 256-258 CODEN: FEBLAL;ISSN: 0014-5793, XP002077929 [A] 1-4,12-19 * the whole document *
		[PX] - ZOU H ET AL, "Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3 [see comments]", CELL, AUG 8 1997, 90 (3) P405-13, UNITED STATES, XP002077930 [PX] 1-5,9,10,12-19 * the whole document *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p